首页|N6-甲基腺苷修饰在动脉粥样硬化中的作用及药物干预的研究进展

N6-甲基腺苷修饰在动脉粥样硬化中的作用及药物干预的研究进展

扫码查看
N6-甲基腺苷(m6A)修饰是真核生物mRNA中最常见的表观转录组修饰形式之一,具有动态可逆性.该修饰过程由甲基转移酶、去甲基化酶和与m6A结合的蛋白质协同作用,影响mRNA的代谢和功能.越来越多的研究表明,m6A RNA修饰在动脉粥样硬化(As)等多种疾病的发生和发展中扮演重要角色.文章综述了 m6A RNA修饰与As的关系.全文对m6A RNA修饰机制以及在As相关细胞(如内皮细胞、巨噬细胞和平滑肌细胞)中的作用进行了全面总结,并探讨了 m6A RNA修饰与As危险因素,如高脂饮食、缺血缺氧、振荡应力及高血压的关联.最后,文章还对药物干预m6A RNA甲基化以实现延缓As的研究进行了综述,为探索As早期诊断和治疗的新靶点提供了重要参考.
Research progress on the role of N6-methyladenosine modification in atherosclerosis and drug intervention
N6-methyladenosine(m6A)modification is one of the most abundant epitranscriptomic modifications in eukaryotic mRNA,with dynamic and reversible properties.This modification process is coordinated by methyltransferases,demethylases,and related m6A binding proteins,which in turn affect mRNA metabolism and function.Increasing evi-dence has indicated that the m6A RNA modification plays an important role in the occurrence and development of athero-sclerosis(As)and other related diseases.This paper provide a comprehensive review of the relationship between m6A RNA modification and As.The entire manuscript summarizes the m6A RNA modification mechanism and its roles in As-related cells including endothelial cells,macrophages,and smooth muscle cells,and discusses the association of m6A RNA modification with risk factors of As such as high-fat diet,ischemia/hypoxia,oscillatory stress,and hypertension.Finally,this review summarizes researches on drug intervention targeting m6A RNA methylation to mitigate As.These studies pro-vide important references for exploring new targets for early diagnosis and treatment of As.

atherosclerosisN6-methyladenosine modificationmethyltransferasesdemethylasesdrug intervention

张晓璐、耿妙颖、王雲、蒙胜勇、王一婧、姜希娟

展开 >

天津中医药大学,天津市 301617

动脉粥样硬化 N6-甲基腺苷修饰 甲基转移酶 去甲基化酶 药物干预

国家自然科学基金项目天津中医药大学中西医结合学院2019年度研究生创新基金项目

82074211和81804025ZXYCXLX201902

2024

中国动脉硬化杂志
中国病理生理学会 南华大学

中国动脉硬化杂志

CSTPCD
影响因子:1.086
ISSN:1007-3949
年,卷(期):2024.32(4)
  • 1
  • 1